By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Epigenomics AG 

Kleine Präsidentenstraße 1

Berlin    D-10178  Germany
Phone: 49-30-24-34-5-0 Fax: +49-30-24-34-55-55



Company News
Epigenomics AG Announces 2014 Third Quarter And Nine Month Financial Results And Reports On Operational Highlights 11/11/2014 11:38:02 AM
Epigenomics AG’ Strategic Commercialization Partner Polymedco Reiterates Its Commitment To Support Epi proColon® In The United States 11/3/2014 1:11:36 PM
Results Of Adherence Study Published In BMC Gastroenterology Demonstrate That Epigenomics AG’ Blood-Based Epi Procolon® Improves Compliance To CRC Screening 10/27/2014 9:34:11 AM
Epigenomics AG Raises USD 5.3 Million From Its Strategic Commercialization Partner Biochain Institute, Inc. 10/16/2014 2:00:29 PM
Epigenomics AG Provides Corporate Update 10/1/2014 10:38:04 AM
Epigenomics AG Converts To Registered Shares 9/19/2014 12:32:07 PM
Epigenomics AG Announces H1 2014 And Q2 2014 Financial Results And Reports On Operational Highlights 8/12/2014 12:48:05 PM
Epigenomics AG Provides Update On Regulatory Status And Information On Additional Clinical Study For Epi proColon® In The U.S. 7/1/2014 10:38:02 AM
Epigenomics AG Announces Publication Of Results Of Two U.S. Clinical Studies With Its Blood-based Epi proColon® CRC Screening Test 6/24/2014 8:59:05 AM
FDA Issues Response Letter For Epigenomics AG's Colorectal Cancer Screening Blood Test Epi Procolon® Requesting Further Data Pre-Approval 6/2/2014 2:52:09 PM